MICHAEL LEVY: Open Payments
NPI 1912124959 · NYACK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$368 in 23 payments from 6 companies in 2025. Trend: 2023 $503 · 2024 $280 · 2025 $368
Food & beverage: $368
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $204 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Alkermes, Inc. | 1 | $23 |
| Currax Pharmaceuticals LLC | 1 | $15 |
Products named: VRAYLAR, REXULTI, COBENFY, UZEDY, ARISTADA, CONTRAVE.
Industry payments across NY — which companies pay providers there.
